Investor Summary

Every year, over 15 million people worldwide suffer a stroke, and up to 30% develop acquired dyslexia—a sudden, disabling loss of reading fluency, handwriting control, and visual-verbal coordination due to focal brain injury. Unlike developmental dyslexia, this condition emerges abruptly and profoundly impacts independence—yet it is rarely addressed in standard stroke rehabilitation, which focuses almost exclusively on motor recovery.

At O’VISTA, we apply a simple but powerful principle: if muscles need physiotherapy after stroke, so does the brain. Our platform delivers the world’s first AI-powered cognitive physiotherapy system for post-stroke acquired dyslexia—using real-time eye tracking to detect stroke-specific oculomotor signatures and delivering adaptive, gamified therapy through a 50-inch touchscreen + balance board interface.

We detect key biomarkers such as:

• Asymmetric saccades (indicating hemispatial neglect or parietal damage)
• Fixation instability and line-loss during reading
• Disrupted handwriting-eye coordination—a hallmark of acquired dyslexia
• Impaired binocular alignment and smooth pursuit

These signals guide a personalized recovery protocol that:

• Rebuilds eye-hand synchrony through rhythmic, gaze-guided tracing
• Restores reading fluency using adaptive line-highlighting and prosody-based audio
• Enhances neuroplasticity by coupling visual attention, motor control, and phonological feedback

O’VISTA treats acquired dyslexia not as a static deficit, but as a dynamic recovery process—monitoring progress weekly and adjusting therapy intensity in real time.

We are launching first in the Gulf Cooperation Council (GCC) and Middle East, where:

• Stroke incidence is rising due to aging populations and high rates of hypertension/diabetes
• Private hospitals and rehab centers are digitizing rapidly
• Regulatory pathways for AI-enabled neurorehab tools are significantly more agile than in the EU or U.S.
• There is strong cultural emphasis on restoring dignity and functional independence

This region serves as an ideal clinical and commercial beachhead—enabling rapid validation, reimbursement pilots, and integration into national stroke recovery protocols.

Success here de-risks global expansion into Europe, Canada, the U.S., and Australia, where post-stroke cognitive rehab markets exceed $4.2 billion annually—yet remain underserved by scalable, objective, brain-first tools.

O’VISTA transforms stroke recovery from a purely physical journey into a comprehensive brain-body restoration process. We invite investors to join us in building the future of cognitive rehabilitation—starting in the Gulf, scaling worldwide.